Author:
Sullivan Patrick S.,Mena Leandro,Elopre Latesha,Siegler Aaron J.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Reference91 articles.
1. Office of National AIDS Policy. National HIV/AIDS strategy for the United States: updated to 2020 [online national strategy document]. 2015. Available at:
https://www.aids.gov/federal-resources/national-hiv-aids-strategy/nhas-update.pdf
. last accessed November 1, 2015.
2. Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA. 2019;321:844.
3. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.
https://doi.org/10.1056/NEJMoa1011205
.
4. Sullivan PS, Giler RM, Mouhanna F, Pembleton ES, Guest JL, Jones J, et al. Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017. Ann Epidemiol. 2018;28(12):833–40.
https://doi.org/10.1016/j.annepidem.2018.06.009
.
5. Siegler AJ, Mouhanna F, Giler RM, Weiss K, Pembleton E, Guest J, et al. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States. Ann Epidemiol. 2018;28(12):841–9.
https://doi.org/10.1016/j.annepidem.2018.06.005
.
Cited by
127 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献